Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 7 of 59, showing 5 Applications out of 292 total, starting on record 31, ending on 35

# Protocol No Study Title Investigator(s) & Site(s) Application Status

31.

ECCT/13/08/06  
    Management of myocardial injury After NoncArdiac surgGEry (MANAGE) Trial   
Principal Investigator(s)
1. GERALD OCHIENG\' YONGA
2. LEONARD MZEE NGUNGA
Site(s) in Kenya
Aga Khan University Hospital, Nairobi
 
Trial Status Recruiting
Protocol Date 30-11-2012
View

32.

ECCT/16/05/02   Monitoring Pre-exposure Prophylaxis for Young Adult women (MPYA)
    Next generation real-time monitoring for PrEP adherence in young Kenyan women   
Principal Investigator(s)
1. Nelly Rwamba Mugo
Site(s) in Kenya
1. Thika Partners Study Clinic (Partners in Health Research and Development) (Kiambu county)
2. Partners in Prevention, Kisumu Site (Kisumu county)
 
Trial Status Analysing
Protocol Date 19-04-2016
View

33.

ECCT/16/12/03   The Partners Scale-Up Project
    An implementation project to scale-up delivery of antiretroviral-based HIV-1 prevention among Kenyan HIV-1 serodiscordant couples   
Principal Investigator(s)
1. Nelly Rwamba Mugo
Site(s) in Kenya
1. Thika Level 5 Hospital, Ruiru Sub-County Hospital, Kiambu County Hospital, Kikuyu PCEA Hospital (Kiambu county)
2. Coptic Hospital, Mbagathi Hospital, St. Mary\'s Hospital, Pumwani Maternity Hospital (Nairobi City county)
3. Nyeri PGH, Karatina Sub-County Hospital, (Nyeri county)
4. Kerugoya County Hospital (Kirinyaga county)
5. Murang\'a County Hospital (Murang\'a county)
 
Trial Status Writing-up
Protocol Date 24-10-2016
View

34.

ECCT/16/11/02   IMPAACT P1093
    Phase I/II, Multi-Center, Open-Label Pharmacokinetic, Safety, Tolerability and Antiviral Activity of Dolutegravir, a Novel Integrase Inhibitor, in Combination Regimens in HIV-1 Infected Infants, Children and AdolescentsPhase I/II, Multi-Center, Open-Label Pharmacokinetic, Safety, Tolerability and Antiviral Activity of Dolutegravir, a Novel Integrase Inhibitor, in Combination Regimens in HIV-1 Infected Infants, Children and Adolescents   
Principal Investigator(s)
1. Lucy Koech
Site(s) in Kenya
KENYA MEDICAL RESEARCH INSTITUTE/WALTER REED PROJECT HIV PROGRAME
 
Trial Status In follow-up
Protocol Date 13-04-2016
View

35.

ECCT/17/08/04   P1081
    A PHASE IV RANDOMIZED TRIAL TO EVALUATE THE VIROLOGIC RESPONSE AND PHARMACOKINETICS OF TWO DIFFERENT POTENT REGIMENS IN HIV INFECTED WOMEN INITIATING TRIPLE ANTIRETROVIRAL REGIMENS BETWEEN 28 AND 36 WEEKS OF PREGNANCY FOR THE PREVENTION OF MOTHER-TO-CHILD TRANSMISSION:    NICHD P1081   
Principal Investigator(s)
1. FREDRICK KIPYEGON SAWE
Site(s) in Kenya
Kenya Medical Research Institute Walter Reed Project Clinical Research Centre.
 
Trial Status Stopped
Protocol Date 02-04-2015
View